BUY Ajanta Pharma Limited — Kshitija Salvi, Globe Capital Market
byKshitija Salvi, Globe Capital MarketHorizon: NA (inferred Swing (≤2wk))8 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·7 Jul · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ajanta Pharma
- BUY — Manas Jaiswal23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY — Aastha Jain, Hem Securities30 Sept 2026 · Next day · target ₹3,800 · SL hit
- BUY — Sahi Research24 Sept 2026 · ~2 weeks · target ₹3,780 · SL hit
- BUY — Siddharth Rai Mangala18 Sept 2026 · ~2 weeks · target ₹3,770 · SL hit
- BUY — Kush Bohra17 Aug 2026 · ~2 weeks · target ₹3,860 · SL hit
More from Kshitija Salvi, Globe Capital Market
- BUY Laurus Labs11 Sept 2026 · ~2 weeks · target ₹2,140 · SL hit
- BUY Ather Energy10 Sept 2026 · ~2 weeks · target ₹1,760 · SL hit
- BUY Cholamandalam Investment and Finance Company10 Sept 2026 · ~2 weeks · target ₹1,985 · SL hit
- BUY Adani Ports and Special Economic Zone9 Sept 2026 · ~2 weeks · target ₹1,900 · Expired
- BUY Hindustan Zinc8 Sept 2026 · ~2 weeks · target ₹650 · SL hit

